Docmode Health Technologies Limited — Results, 30-05-2025: Integrated Filing- Financial

DocMode Health Technologies Limited has announced a board meeting to approve the financial results for the quarter and half-year.

1) **Revenue Performance:** Consolidated revenue grew 4.4% YoY to ₹41.77 Cr from ₹40.01 Cr, supported mainly by steady activity in its core "Transforming Learning and Practice" segment focused in India.

2) **Profitability and EPS:** The company posted a consolidated net loss of ₹2.03 Cr versus a net profit of ₹0.19 Cr last year. EPS turned negative at -₹6.45 from ₹0.60, driven by margin pressure from rising costs and muted earnings.

3) **Operational Costs:** Total expenses increased notably to ₹44.67 Cr from ₹39.80 Cr, largely due to higher purchases/consumption (₹44.77 Cr vs ₹31.37 Cr) and other expenses, despite employee costs reducing to ₹3.76 Cr from ₹4.95 Cr. Finance costs edged up slightly. Inventory levels jumped sharply, signaling stock accumulation or scale-up efforts.

4) **Key Metrics:** While EBITDA figures are not disclosed, operating losses widened to ₹1.97 Cr compared to a profit last year. The significant inventory build (+~₹8.6 Cr if converted, actual ₹86 Cr noted likely a typo) calls for close working capital monitoring.

5) **Balance Sheet / Cash Flow Health:** Long-term borrowings fell substantially, but short-term debt rose. Trade payables and current liabilities increased, indicating a stretched working capital cycle. Cash reserves dropped to ₹1.84 Cr from ₹3.10 Cr. Operating cash flow improved to ₹6.68 Cr, enabling ₹3.65 Cr capex mainly in IT and intangibles.

6) **Management Outlook:** IPO proceeds of ₹6.71 Cr have been fully deployed as planned toward IT infrastructure, working capital, and corporate needs. The focus remains on scaling the core platform and enhancing operational efficiency.

**Takeaway:** DocMode shows stable revenue growth but expanding losses due to rising costs and inventory buildup. Investments in capex and working capital hint at growth ambitions, yet profitability remains a key concern. Retail investors should monitor margin recovery and working capital trends closely before committing, as the company is in a development phase with negative earnings and cash outflows despite business stability.